, Singapore
Photo from Freepik

Cordlife to resume cord blood banking in 'controlled manner'

It can only collect 30 units per month of new cord blood.

Cordlife will resume its cord blood banking services in a "controlled manner" after receiving approval from the Ministry of Health (MOH).

Under MOH's conditions, Cordlife can only collect, test, process, and store a maximum of 30 units per month of new cord blood from infant donors between 15 September and 13 January 2025

Based on MOH’s findings, Cordlife has complied with the necessary standards to resume its cord blood banking services, which include validating the AXP II System for processing cord blood, establishing a new temperature monitoring system with satisfactory practices, and optimising its incident tracking and escalation workflow.

Despite the progress, MOH indicated that Cordlife needs to improve the effectiveness of its CGL's supervisory approach and maintain consistency in its risk and issue impact analyses. Cordlife also has yet to complete the testing of low-risk tanks.

Meanwhile, the company said its inability to fully resume operations will likely result in a negative financial impact for FY2024.

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.